Healthcare real estate investment trust (REIT) Ventas, Inc. (VTR - Free Report) is scheduled to report third-quarter 2017 results on Oct 27, before the market opens. The company’s funds from operations (FFO) and revenues are anticipated to be up year over year.
Last quarter, this Chicago, IL-based healthcare REIT delivered a positive surprise of 0.95%. Results reflected growth in same-store cash net operating income (NOI) across triple net-leased portfolio, senior housing operating portfolio and medical office building portfolio.
Further, Ventas posted an average positive surprise of 0.99% over the trailing four quarters, surpassing estimates twice and posting in-line results in the other occasions. The graph below depicts this surprise history:
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Healthcare real estate investment trust (REIT) Ventas, Inc. (VTR - Free Report) is scheduled to report third-quarter 2017 results on Oct 27, before the market opens. The company’s funds from operations (FFO) and revenues are anticipated to be up year over year.
Last quarter, this Chicago, IL-based healthcare REIT delivered a positive surprise of 0.95%. Results reflected growth in same-store cash net operating income (NOI) across triple net-leased portfolio, senior housing operating portfolio and medical office building portfolio.
Further, Ventas posted an average positive surprise of 0.99% over the trailing four quarters, surpassing estimates twice and posting in-line results in the other occasions. The graph below depicts this surprise history:
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on VTR - FREE
Get the latest research report on BXP - FREE
Get the latest research report on CUZ - FREE
Get the latest research report on COR - FREE